- Home
- WOLF vs AMLX Comparison
WOLF vs AMLX Comparison
Compare WOLF & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOLF
- AMLX
- Stock Information
- Founded
- WOLF 1987
- AMLX 2014
- Country
- WOLF United States
- AMLX United States
- Employees
- WOLF N/A
- AMLX N/A
- Industry
- WOLF Semiconductors
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- WOLF Technology
- AMLX Health Care
- Exchange
- WOLF Nasdaq
- AMLX Nasdaq
- Market Cap
- WOLF 838.3M
- AMLX 1.3B
- IPO Year
- WOLF 1993
- AMLX 2022
- Fundamental
- Price
- WOLF $19.67
- AMLX $12.46
- Analyst Decision
- WOLF Hold
- AMLX Strong Buy
- Analyst Count
- WOLF 9
- AMLX 7
- Target Price
- WOLF $11.13
- AMLX $17.43
- AVG Volume (30 Days)
- WOLF 2.6M
- AMLX 1.5M
- Earning Date
- WOLF 10-29-2025
- AMLX 11-06-2025
- Dividend Yield
- WOLF N/A
- AMLX N/A
- EPS Growth
- WOLF N/A
- AMLX N/A
- EPS
- WOLF N/A
- AMLX N/A
- Revenue
- WOLF $759,700,000.00
- AMLX N/A
- Revenue This Year
- WOLF $16.42
- AMLX N/A
- Revenue Next Year
- WOLF N/A
- AMLX N/A
- P/E Ratio
- WOLF N/A
- AMLX N/A
- Revenue Growth
- WOLF N/A
- AMLX N/A
- 52 Week Low
- WOLF $1.20
- AMLX $2.60
- 52 Week High
- WOLF $36.60
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- WOLF 41.69
- AMLX 39.46
- Support Level
- WOLF $16.75
- AMLX $11.79
- Resistance Level
- WOLF $19.04
- AMLX $13.17
- Average True Range (ATR)
- WOLF 2.30
- AMLX 0.70
- MACD
- WOLF -1.79
- AMLX -0.30
- Stochastic Oscillator
- WOLF 18.04
- AMLX 18.84
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.